Bill > HR8845

This bill, the Medicare Multi-Cancer Early Detection Screening Coverage Act of 2020, aims to amend Title XVIII of the Social Security Act to provide Medicare coverage for multi-cancer early detection screening tests. The key provisions of the bill include: 1) defining "multi-cancer early detection screening tests" as FDA-approved genomic sequencing blood or blood product tests that analyze cell-free nucleic acids, or other equivalent tests based on urine or other biological samples, to screen for multiple types of cancer; 2) requiring Medicare to cover these multi-cancer early detection screening tests as a new benefit; 3) limiting payment for these tests to once per 12-month period; and 4) clarifying that coverage of these tests would not affect coverage of other Medicare-covered cancer screening tests, such as mammograms and colonoscopies.